1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BA5B42D00EE60C03652583A200169C72
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/how-medical-affairs-can-deliver-value-to-internal-stakeholders-collaborations-challenges-mitigation-tactics
18
19
2018.215.159.156
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Affairs Excellence

How Medical Affairs Can Deliver Value to Internal Stakeholders: Collaborations, Challenges & Mitigation Tactics

ID: 5546


Features:

10 Info Graphics

10 Data Graphics

130+ Metrics

33 Narratives


Pages/Slides: 26


Published: 2019


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “How Medical Affairs Can Deliver Value to Internal Stakeholders: Collaborations, Challenges & Mitigation Tactics”

STUDY OVERVIEW

In the past decade Medical Affairs has significantly evolved to provide strategic value to a wide range of internal stakeholders - including commercial, managed markets, clinical development, drug safety and regulatory teams. However, for Medical Affairs to deliver its maximum potential, it is important to foster better collaboration with these critical internal functions.

Best Practices, LLC undertook this benchmarking research to probe Medical Affairs' role in working with internal stakeholders. This study also uncovers mitigation tactics to overcome the many challenges encountered in improving the perception of the value Medical Affairs brings to an organization.

KEY TOPICS

  • Effectiveness/Importance of Medical Affairs Collaborations with Internal Stakeholders
  • Major Challenges Facing Medical Affairs and Mitigation Tactics to Overcome Them

KEY METRICS
  • How effective is your Medical Affairs organization at delivering value in the listed areas?
  • How important is your work to help each function achieve its business objectives?
  • What information does your Chief Medical Officer share with other C-suite members in regards to Medical Affairs?
  • Select and describe the challenges Medical Affairs faces in improving the perception of the value it brings to your company

SAMPLE KEY FINDING
  • Use a strategic mindset when sharing information with C-suite and other decision-makers: For greater value, the information shared with C-suite and senior leadership should be more transformational and strategic in nature; move from sharing project plans and budgets to discussing how Medical Affairs is impacting company’s strategic goals. Examples: Use of field medical teams to improve managed care penetration and use of artificial intelligence to boost medical’s effectiveness.

METHODOLOGY

Best Practices, LLC engaged 47 Medical Affairs experts from 34 leading companies in this research through a benchmarking survey, interviews and a roundtable discussion. Ninety percent of the research partners serve at the Director / Head level and above.


Industries Profiled:
Diagnostic; Biotech; Medical Device; Pharmaceutical; Consumer Products; Health Care; Biopharmaceutical; Communications; Clinical Research; Laboratories


Companies Profiled:
Abbott Vascular; Accera; Actelion; Ascensia; Astellas; AstraZeneca; Bayer Healthcare; Boehringer Ingelheim; cipla; Eisai; EMD Serono; Ferring Pharmaceuticals; GlaxoSmithKline ; Grifols; Heron Therapeutics; Intercept; Ironwood; Janssen; Johnson & Johnson; LEO Pharma; MedThink; Merck KGaA; Merck Sharp & Dohme; Novartis; Novo Nordisk; Pfizer; Roche; Sage Therapeutics; Sanofi; Sanofi Pasteur; Santen; Sunovion; Teva Pharmaceutical Industries Ltd; Vifor Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.